Case number 1:22-cv-01492
Bayer Intellectual Property GMBH et al v. USV Private Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 22, 2023 | 25 | REDACTED VERSION of 20 Letter, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/22/2023 (nms). (Entered: 06/22/2023) (1) |
| Jun 21, 2023 | 24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,539,218 B2; US 10,828,310 B2. (Attachments: # 1 Order)(nms) (Entered: 06/21/2023) (Main Document) (1) |
| Jun 21, 2023 | N/A | CASE CLOSED per D.I. 23 . (nms) (Entered: 06/21/2023) (0) |
| Jun 21, 2023 | 23 | SO ORDERED Granting (D.I. 161 in 21-md-3017-RGA; D.I. 22 in 22-cv-1492-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 06/21/2023) (2) |
| Jun 21, 2023 | 24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,539,218 B2; US 10,828,310 B2. (Attachments: # 1 Order)(nms) (Entered: 06/21/2023) (Order) (2) |
| Jun 20, 2023 | 22 | STIPULATION of Dismissal by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 06/20/2023) (2) |
| Jun 16, 2023 | 21 | ORAL ORDER: The request to file another status report by 6/22/2023 (D.I. 20 in 22-cv-1492-RGA; D.I. 157 in 21-md-3017-RGA) is GRANTED. Ordered by Judge Richard G. Andrews on 6/16/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 06/16/2023) (0) |
| Jun 15, 2023 | 20 | [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 6/16/2023 (nms). (Entered: 06/15/2023) (0) |
| Jun 12, 2023 | 19 | ORAL ORDER: Defendant USV Private Limited's answer was due to be filed on 6/8/2023 (see D.I. 153 in MDL 21-3017; D.I. 18 in C.A. 22-1492), and to date none has been filed. A status letter is now due no later than three (3) days from the entry of this Order. Ordered by Judge Richard G. Andrews on 6/12/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 06/12/2023) (0) |
| Jun 1, 2023 | N/A | SO ORDERED, re 18 Unopposed Motion to Extend Time (*Reset Answer Deadlines: USV Private Limited answer due 6/8/2023). Signed by Judge Richard G. Andrews on 6/1/2023. (nms) (Entered: 06/01/2023) (0) |
| May 31, 2023 | 18 | Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/1/2023 (nms). Modified on 6/1/2023 (nms). (Entered: 05/31/2023) (3) |
| Apr 27, 2023 | N/A | SO ORDERED, re 17 Unopposed Motion to Extend Time (*Reset Answer Deadlines: USV Private Limited answer due 6/1/2023). Signed by Judge Richard G. Andrews on 4/27/2023. (nms) (Entered: 04/27/2023) (0) |
| Apr 27, 2023 | 17 | Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 4/27/2023 (nms). (Entered: 04/27/2023) (3) |
| Mar 24, 2023 | N/A | SO ORDERED, re (D.I. 148 in 21-md-3017-RGA; D.I. 16 in 22-cv-1492-RGA) Unopposed Motion to Extend Time to Answer or otherwise respond to the Complaint to May 1, 2023. Signed by Judge Richard G. Andrews on 3/24/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 03/24/2023) (0) |
| Mar 24, 2023 | 16 | UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until to May 1, 2023 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 3/24/2023 (nms). (Entered: 03/24/2023) (3) |
| Feb 28, 2023 | 15 | UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until March 30, 2023 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/28/2023 (nms). (Entered: 02/28/2023) (3) |
| Feb 28, 2023 | N/A | SO ORDERED, re ( D.I. 15 in 22-cv-1492-RGA; D.I. 141 in 21-md-3017-RGA) UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until March 30, 2023. Signed by Judge Richard G. Andrews on 2/28/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 02/28/2023) (0) |
| Jan 31, 2023 | 14 | Unopposed Motion for Extension of Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/31/2023 (nms). (Entered: 01/31/2023) (3) |
| Jan 31, 2023 | N/A | SO ORDERED, re (D.I. 139 in 21-md-3017-RGA; D.I. 14 in 22-cv-1492-RGA) Unopposed Motion for Extension of Time to answer or otherwise respond to the Complaint until 2/28/2023. Signed by Judge Richard G. Andrews on 1/31/2023. Associated Cases: 1:22-cv-01492-RGA, 1:21-md-03017-RGA(nms) (Entered: 01/31/2023) (0) |
| Jan 23, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by USV Private Limited. (Green, James) (Entered: 01/23/2023) (1) |
| Jan 18, 2023 | N/A | DEFICIENCY NOTICE issued by the Court to Defendant: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) (Entered: 01/18/2023) (0) |
| Jan 5, 2023 | N/A | SO ORDERED, Granting (D.I. 12 in 22-cv-1492-RGA; D.I. 136 in 21-md-3017-RGA) Unopposed Motion to Extend Time to answer or otherwise respond to Complaint to January 31, 2023. Signed by Judge Richard G. Andrews on 1/5/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 01/05/2023) (0) |
| Jan 4, 2023 | 12 | UNOPPOSED Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/5/2023 (nms). (Entered: 01/04/2023) (3) |
| Dec 14, 2022 | 11 | NOTICE of Appearance by James S. Green, Jr on behalf of USV Private Limited (Green, James) (Entered: 12/14/2022) (1) |
| Dec 5, 2022 | N/A | SO ORDERED, re (D.I. 10 in 22-cv-1492-RGA; D.I. 128 in 21-md-3017-RGA) UNOPPOSED Motion to Extend Time to answer the complaint to 1/5/2023. Signed by Judge Richard G. Andrews on 12/5/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 12/05/2022) (0) |
| Dec 5, 2022 | 10 | UNOPPOSED Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/5/2022 (nms). (Entered: 12/05/2022) (3) |
| Nov 15, 2022 | N/A | NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. (smg) (Entered: 11/15/2022) (0) |
| Nov 15, 2022 | 9 | Record of case transferred in from District of New Jersey; Case Number in Other District: 2:22-cv-05485. Copy of Docket Sheet and original file (Entered: 11/15/2022) (Main Document Public Docket Sheet) (2) |
| Nov 14, 2022 | N/A | NOTICE TO COUNSEL: MDL No. 1:2021-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may request E-Filing rights through PACER and add the MDL case number in the comments section of your request. Please see the docket for further entries. (smg) (Entered: 11/15/2022) (0) |
| Nov 14, 2022 | 8 | Order of MDL Panel transferring case to the District of Delaware. (In Re: Xarelto (Rivaroxaban)('310) Patent Litigation MDL 3017 CTO 2 - Judge Richard G. Andrews) (gh, ) [Transferred from New Jersey on 11/15/2022.] (Entered: 11/14/2022) (2) |
| Oct 17, 2022 | 7 | Letter from Keith J. Miller, Esq. to Hon. Leda D. Wettre, U.S.M.J. re 3 Order,. (MILLER, KEITH) [Transferred from New Jersey on 11/15/2022.] (Entered: 10/17/2022) (1) |
| Oct 12, 2022 | N/A | Minute Entry for proceedings held before Magistrate Judge Leda D. Wettre: Status Conference held on 10/12/2022. (ECR/ATT) (LM, ) [Transferred from New Jersey on 11/15/2022.] (Entered: 10/12/2022) (0) |
| Oct 5, 2022 | 6 | TEXT ORDER: The telephone conference set for October 12, 2022 will now proceed at 2:30 p.m. before Magistrate Judge Leda D. Wettre for the purpose of making disclosures. Dial-in information for the conference is (888) 684-8852, access code 8948139. Plaintiffs' counsel shall advise counsel for defendant of the time, date, and dial-in information for the conference. Kindly mark your calendars accordingly. So Ordered by Magistrate Judge Leda D. Wettre on 9/21/2022. (LM, ) [Transferred from New Jersey on 11/15/2022.] (Entered: 10/05/2022) (0) |
| Sep 15, 2022 | 5 | AO120 Patent Form filed. (Attachments: # 1 Complaint) (lag, ) [Transferred from New Jersey on 11/15/2022.] (Entered: 09/15/2022) (Main Document) (1) |
| Sep 15, 2022 | 4 | SUMMONS ISSUED as to USV PRIVATE LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (lag, ) [Transferred from New Jersey on 11/15/2022.] (Entered: 09/15/2022) (2) |
| Sep 15, 2022 | 5 | AO120 Patent Form filed. (Attachments: # 1 Complaint) (lag, ) [Transferred from New Jersey on 11/15/2022.] (Entered: 09/15/2022) (Complaint) (30) |
| Sep 14, 2022 | 3 | TEXT ORDER: A telephone conference is set for October 12, 2022 at 3:00 p.m. before Magistrate Judge Leda D. Wettre for the purpose of making disclosures. Plaintiffs' counsel shall advise counsel for defendant of the time, date, and dial-in information for the conference. Dial-in information for the conference is (888) 684-8852, access code 8948139. So Ordered by Magistrate Judge Leda D. Wettre on 9/14/22. (LM, ) [Transferred from New Jersey on 11/15/2022.] (Entered: 09/14/2022) (0) |
| Sep 12, 2022 | 2 | Corporate Disclosure Statement by BAYER AG, BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG identifying Bayer AG as Corporate Parent.. (MILLER, KEITH) [Transferred from New Jersey on 11/15/2022.] (Entered: 09/12/2022) (2) |
| Sep 9, 2022 | 1 | COMPLAINT against USV Private Limited (Filing and Admin fee $ 402 receipt number ANJDC-13681129), filed by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property Gmbh, Bayer Ag, Bayer Pharma Ag. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(MILLER, KEITH) [Transferred from New Jersey on 11/15/2022.] Modified on 1/18/2023 (nms). (Entered: 09/09/2022) (Main Document) (18) |
| Sep 9, 2022 | 1 | COMPLAINT against USV Private Limited (Filing and Admin fee $ 402 receipt number ANJDC-13681129), filed by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property Gmbh, Bayer Ag, Bayer Pharma Ag. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(MILLER, KEITH) [Transferred from New Jersey on 11/15/2022.] Modified on 1/18/2023 (nms). (Entered: 09/09/2022) (Exhibit A to Complaint) (14) |
| Sep 9, 2022 | 1 | COMPLAINT against USV Private Limited (Filing and Admin fee $ 402 receipt number ANJDC-13681129), filed by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property Gmbh, Bayer Ag, Bayer Pharma Ag. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(MILLER, KEITH) [Transferred from New Jersey on 11/15/2022.] Modified on 1/18/2023 (nms). (Entered: 09/09/2022) (Exhibit B to Complaint) (27) |
| Sep 9, 2022 | 1 | COMPLAINT against USV Private Limited (Filing and Admin fee $ 402 receipt number ANJDC-13681129), filed by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property Gmbh, Bayer Ag, Bayer Pharma Ag. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(MILLER, KEITH) [Transferred from New Jersey on 11/15/2022.] Modified on 1/18/2023 (nms). (Entered: 09/09/2022) (Civil Cover Sheet) (2) |
